Clinical Trial Update: Vivatlac in Irritable Bowel Syndrome II (ViIBS2) [NA]

View source ↗

Summary

Clinical trial update indicates ongoing recruitment for ViIBS2 evaluating Vivatlac in Irritable Bowel Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Vivatlac

Snippet

Sponsor: The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz | Conditions: Irritable Bowel Syndrome | NA | Status: RECRUITING